VELA Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$534K Sell
2,454
-4,991
-67% -$1.11M 0.12% 142
2025
Q4
$1.7M Sell
7,445
-2,978
-29% -$678K 0.4% 81
2025
Q3
$2.41M Sell
10,423
-135
-1% -$27.5K 0.59% 54
2025
Q2
$1.96M Sell
10,558
-1,487
-12% -$276K 0.53% 62
2025
Q1
$2.52M Sell
12,045
-991
-8% -$193K 0.79% 41
2024
Q4
$2.32M Sell
13,036
-18
-0.1% -$3.31K 0.65% 53
2024
Q3
$2.58M Sell
13,054
-1,043
-7% -$195K 0.8% 38
2024
Q2
$2.42M Buy
14,097
+1,020
+8% +$169K 0.75% 44
2024
Q1
$2.38M Sell
13,077
-4,590
-26% -$791K 0.81% 39
2023
Q4
$2.74M Buy
17,667
+914
+5% +$133K 1.05% 22
2023
Q3
$2.5M Buy
16,753
+822
+5% +$121K 1.1% 24
2023
Q2
$2.15M Sell
15,931
-2,607
-14% -$382K 0.99% 32
2023
Q1
$2.95M Buy
18,538
+376
+2% +$57.5K 1.34% 17
2022
Q4
$2.94M Hold
18,162
1.45% 17
2022
Q3
$2.44M Buy
18,162
+720
+4% +$103K 1.38% 20
2022
Q2
$2.67M Buy
17,442
+1,629
+10% +$249K 1.53% 15
2022
Q1
$2.56M Sell
15,813
-1,680
-10% -$244K 1.61% 18
2021
Q4
$2.37M Buy
+17,493
New +$2.07M 1.59% 19

Other funds holding ABBV

VELA Investment Management's ABBV Position: Q1 2026 in Review

VELA Investment Management reduced its AbbVie (ABBV) stake by 67% in Q1 2026, selling an estimated $1.11M and leaving 2,454 shares worth $534K. The position accounts for 0.12% of the portfolio, ranked #142.

VELA Investment Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.95M in Q1 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • VELA Investment Management held 2,454 shares of AbbVie worth $534K as of Q1 2026.
  • VELA Investment Management sold 4,991 AbbVie shares in Q1 2026, an estimated $1.11M.
  • AbbVie made up 0.12% of VELA Investment Management's portfolio in Q1 2026, its #142 holding.
  • VELA Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • VELA Investment Management's AbbVie position peaked at $2.95M in Q1 2023.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on VELA Investment Management's 13F filing for Q1 2026, filed 8 May 2026.